0001415889-23-009556.txt : 20230609
0001415889-23-009556.hdr.sgml : 20230609
20230609210505
ACCESSION NUMBER: 0001415889-23-009556
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sheena Jonathan
CENTRAL INDEX KEY: 0001646649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 231006923
MAIL ADDRESS:
STREET 1: C/O NATERA, INC.
STREET 2: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-06092023_090601.xml
X0407
4
2023-06-07
0001604821
Natera, Inc.
NTRA
0001646649
Sheena Jonathan
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
true
false
false
true
CO-FOUNDER
1
Common Stock
2023-06-07
4
S
0
1717
48.5415
D
518029
D
Common Stock
2023-06-07
4
S
0
3283
49.4308
D
514746
D
Common Stock
2023-06-07
4
S
0
152
48.4157
D
25003
I
By Caraluna Trust 1
Common Stock
2023-06-07
4
S
0
348
49.3910
D
24655
I
By Caraluna Trust 1
Common Stock
2023-06-07
4
S
0
152
48.4138
D
25003
I
By Caraluna Trust 2
Common Stock
2023-06-07
4
S
0
348
49.3924
D
24655
I
By Caraluna Trust 2
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.14 to $49.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.14 to $49.81 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.07 to $49.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.09 to $49.71 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, Attorney-in-Fact
2023-06-09